Boon Cher Goh

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

Cancer research

Nature communications

Cell death discovery

National University of Singapore

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National University of Singapore

Singapore

Deputy Director :: Cancer Science Institute of Singapore

National University Hospital

Singapore

Senior Consultant :: Department of Hematology-Oncology

National University Hospital

Singapore

Director of Research :: Department of Hematology-Oncology

Publications

Xue-Bin Ran, Ling-Wen Ding, Qiao-Yang Sun, Henry Yang, Jonathan W Said, Zhentang Lao, Vikas Madan, Pushkar Dakle, Jin-Fen Xiao, Xinyi Loh, Ying Li, Liang Xu, Xiao-Qiang Xiang, Ling-Zhi Wang, Boon Cher Goh, De-Chen Lin, Wee-Joo Chng, Soo Yong Tan, Sudhakar Jha, H Phillip Koeffler
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy. Cancer research 83 (6) (2023)
Xue-Bin Ran, Ling-Wen Ding, Qiao-Yang Sun, Henry Yang, Jonathan W Said, Zhentang Lao, Vikas Madan, Pushkar Dakle, Jin-Fen Xiao, Xinyi Loh, Ying Li, Liang Xu, Xiao-Qiang Xiang, Ling-Zhi Wang, Boon Cher Goh, De-Chen Lin, Wee-Joo Chng, Soo Yong Tan, Sudhakar Jha, H Phillip Koeffler
Targeting RNA exonuclease XRN1 potentiates efficacy of cancer immunotherapy. Cancer research (2023)
Xue-Bin Ran, Ling-Wen Ding, Qiao-Yang Sun, Henry Yang, Jonathan W Said, Zhentang Lao, Vikas Madan, Pushkar Dakle, Jin-Fen Xiao, Xinyi Loh, Ying Li, Liang Xu, Xiao-Qiang Xiang, Ling-Zhi Wang, Boon Cher Goh, De-Chen Lin, Wee-Joo Chng, Soo Yong Tan, Sudhakar Jha, H Phillip Koeffler
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy. Cancer research 83 (6) (2023)
Heng Boon Low, Zhen Lim Wong, Bangyuan Wu, Li Ren Kong, Chin Wen Png, Yik-Lam Cho, Chun-Wei Li, Fengchun Xiao, Xuan Xin, Henry Yang, Jia Min Loo, Fiona Yi Xin Lee, Iain Bee Huat Tan, Ramanuj DasGupta, Han-Ming Shen, Herbert Schwarz, Nicholas R J Gascoigne, Boon Cher Goh, Xiaohong Xu, Yongliang Zhang
DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell death. Nature communications 12 (1) (2021)
Ser Yue Loo, Nicholas Li-Xun Syn, Angele Pei-Fern Koh, Janet Cheng-Fei Teng, Amudha Deivasigamani, Tuan-Zea Tan, Aye Aye Thike, Shireen Vali, Shweta Kapoor, Xiaoyuan Wang, Jiong-Wei Wang, Puay Hoon Tan, George W Yip, Gautam Sethi, Ruby Yun-Ju Huang, Kam Man Hui, Lingzhi Wang, Boon Cher Goh, Alan Prem Kumar
Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers. Cell death discovery 7 (1) (2021)
Li Ren Kong, Richard Weijie Ong, Tuan-Zea Tan, Nur Afiqah Binte Mohamed Salleh, Matan Thangavelu, Jane Vin Chan, Lie Yong Judice Koh, Giridharan Periyasamy, Jieying Amelia Lau, Thi Bich Uyen Le, Lingzhi Wang, Miyoung Lee, Srinivasaraghavan Kannan, Chandra S Verma, Chwee Ming Lim, Wee Joo Chng, David Philip Lane, Ashok Venkitaraman, Huynh The Hung, Chit Fang Cheok, Boon Cher Goh
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation. Nature communications 11 (1) (2020)
Li Ren Kong, Nur Afiqah Binte Mohamed Salleh, Richard Weijie Ong, Tuan-Zea Tan, Nicholas Li-Xun Syn, Robby Miguel Goh, Chee Wai Fhu, Daniel S W Tan, N Gopalakrishna Iyer, Srinivasaraghavan Kannan, Chandra S Verma, Yaw Chyn Lim, Ross Soo, Jingshan Ho, Yiqing Huang, Joline S J Lim, Benedict Junrong Yan, Min En Nga, Seng Gee Lim, H Phillip Koeffler, Soo Chin Lee, Dennis Kappei, Huynh The Hung, Boon Cher Goh
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma. Nature communications 11 (1) (2020)

Boon Cher Goh.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Boon Cher Goh